Barely Significant
← all excerpts

Radioligand Therapy in Cancer Management: A Global Perspective.

Cancers (Basel) · 2025 · PMC12607575 · PMID 41228206

Europe PMCDOI
1
hedged sentence
0.3000
closest p · 6.0× alpha
0.3000
boldest claim

The sentences

did not reach statistical significancep = 0.30not close (p > 0.1)
The final overall survival (OS) analysis showed a median OS benefit of 11.7 months in the [ 177 Lu]Lu-DOTA-TATE arm; however, the difference did not reach statistical significance ( p = 0.30) [ 20 ].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.